BioCurex, Inc.(fka BOCX)

[i_invest_utrade]

It kind of does make sense.

1. They talk to Abbott or Alere about the posibilites of the peptide, but we don't know which test and data they initially tested for the use of the peptide. Was it the Radio? Serum? POC?

2. We don't know which tests they want to convert using the peptide. It could be the remaining tests they didn't use for a Proof of Concept.

3. They need revenue. The quickest way to revenue would be to choose OncoPet. If they can get any income then let's encourage them to choose the quickest route.


I too am getting tired of the "just around the corner" but at this point we don't have much more to lose. So if just around the corner ends up being a commercially viable cancer test that is better than anything on the market, then call up the Nobel committee.